Hikal has reported results for fourth quarter and year ended March 31, 2022
The company has reported a fall of 59.23% in its net profit at Rs 20.76 crore for the quarter under review as compared to Rs 50.92 crore for the same quarter in the previous year. Total income of the company decreased by 6.11% at Rs 502.62 crore for Q4FY22 as compared Rs 535.33 crore for the corresponding quarter previous year.
For the year ended March 31, 2022, the company has reported a rise of 20.55% in its net profit at Rs 160.51 crore as compared to Rs 133.15 crore for the previous year. Total income of the company increased by 12.88% at Rs 1947.61 crore for year under review as compared to Rs 1725.42 crore for year ended March 31, 2021.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1455.00 |
Dr. Reddys Lab | 5730.85 |
Cipla | 1459.75 |
Zydus Lifesciences | 1007.20 |
Lupin | 1564.60 |
View more.. |